@article{ATM7869,
author = {Binghe Xu and Xichun Hu and Zefei Jiang and Huiping Li and Jiayi Chen and Shude Cui and Qing Li and Ning Liao and Donggeng Liu and Jian Liu and Jinsong Lu and Kunwei Shen and Tao Sun and Yuee Teng and Zhongsheng Tong and Shulian Wang and Xiang Wang and Xiaojia Wang and Yongsheng Wang and Jiong Wu and Peng Yuan and Pin Zhang and Qingyuan Zhang and Hong Zheng and Da Pang and Guosheng Ren and Zhimin Shao and Zhenzhou Shen and Erwei Song and Santai Song},
title = {National consensus in China on diagnosis and treatment of patients with advanced breast cancer},
journal = {Annals of Translational Medicine},
volume = {3},
number = {17},
year = {2015},
keywords = {},
abstract = {The recently available guidelines on the management of advanced breast cancer (ABC) organized by Chinese Anti-Cancer Association, Committee of Breast Cancer Society (CACA-CBCS) do not elucidate ABC in details. To instruct clinicians in treatment of ABC, a Chinese expert consensus meeting on diagnosis and treatment of ABC was held in June 2014 and a consensus is developed. The following consensus provides the level of evidence and supporting documents for each recommendation, and introduces research topics to be urgently addressed. Notably, the consensus on diagnosis and treatment of ABC in China is developed to be applied nationwide. In different areas, multidisciplinary treatment (MDT) tailored to the each patient and the disease itself should be applied based on the basic principles of modern oncology.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/7869}
}